WEHI-539 |
WEHI539 |
1431866-33-9 |
R-(a’)-7-Desmethyl-8-nitro Blebbistatin |
R-(a’)-7-Desmethyl-8-nitro Blebbistatin |
1217619-62-9 |
CCT 244747 |
3-[(1R)-2-(二甲基氨基)-1-甲基乙氧基]-5-[[4-甲氧基-5-(1-甲基-1H-吡唑-4-基)-2-吡啶基]氨基]-2-吡嗪甲腈 |
1404095-34-6 |
GSK J2 |
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1394854-52-4 |
(R)-MG132 |
N-[(苯基甲氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-D-亮氨酰胺 |
1211877-36-9 |
AM-679 |
AM-679 |
1206880-66-1 |
N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1S,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide |
N-[2-[[(2,3-二氟苯基)甲基]硫基]-6-[[(1S,2R)-2,3-二羟基-1-甲基丙基]氨基]-4-嘧啶基]-1-氮杂环丁烷磺酰胺 |
1204707-73-2 |
AMG 232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(异丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
PO-1 |
PO-1 |
1199576-10-7 |
ATI-2341 |
变构激动剂多肽ATI 2341 |
1337878-62-2 |
CHR-6494 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-B]哒嗪-6-胺 |
1333377-65-3 |
TC-F 2 |
TCF-2氢键有机骨架 |
1304778-15-1 |
NVP-BVU 972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]哒嗪-3-基]甲基]喹啉 |
1185763-69-2 |
KN-92 |
KN-92 |
1283519-40-3 |
DPPE FUMARATE |
化合物TESMILIFENE FUMARATE |
1185241-83-1 |
7(S)-Maresin 1 |
7(S)-Maresin 1 |
1268720-66-6 |
AMNA |
AMNA |
1175954-87-6 |
INDY |
INDY |
1169755-45-6 |
3-[4-[[[(3-Methylphenyl)amino]carbonyl]amino]-1H-pyrazol-1-yl]-N-(3,4,5-trimethoxyphenyl)-benzamide |
3-[4-[[[(3-Methylphenyl)amino]carbonyl]amino]-1H-pyrazol-1-yl]-N-(3,4,5-trimethoxyphenyl)-benzamide |
1164153-22-3 |
PF-04217903 |
4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-乙醇 4-羟基苯磺酸盐 |
1159490-85-3 |